Amplify Seymour Cannabis ETF (CNBS) seeks to track the performance of companies involved in the legal cannabis and hemp ecosystem, including cultivators, processors, pharmaceutical companies developing cannabis-based treatments, and ancillary businesses providing specialized services to the cannabis industry.
How It Works
CNBS uses a passive indexing approach to track an underlying cannabis-focused index, investing in companies deriving significant revenue from legal cannabis operations or providing essential services to cannabis businesses. The fund employs market-capitalization weighting with quarterly rebalancing to maintain index alignment. Holdings typically include multi-state operators, Canadian licensed producers, pharmaceutical companies developing cannabinoid therapies, and technology providers serving cannabis businesses.
Key Features
- Pure-play cannabis exposure targeting companies with substantial revenue from legal marijuana operations, not just tangential involvement
- Global diversification across North American cannabis markets including U.S. multi-state operators and Canadian licensed producers
- Includes pharmaceutical companies developing FDA-approved cannabis-based medications alongside traditional cultivation and retail operations
Risks
- This ETF can lose significant value if federal cannabis legalization stalls or reverses, as regulatory uncertainty drives extreme volatility in cannabis stocks
- Individual company failures are magnified due to concentrated exposure to a nascent industry with high bankruptcy rates and operational challenges
- Sector-wide selloffs can cause 40-60% declines during risk-off periods, as cannabis stocks trade more like speculative growth investments than defensive holdings
Who Should Own This
Best suited as a small satellite holding (2-5% maximum allocation) for aggressive growth investors with high risk tolerance and 3+ year time horizons. Appropriate for investors seeking thematic exposure to cannabis legalization trends who can withstand extreme volatility and potential permanent capital loss.